Key result
Application of a TRPA1 agonist to the heart and lung surface resulted in attenuated increases in heart rate, sympathetic output, and mean arterial pressure in chronic heart failure rats.
Why the study?
Excessive sympathoexcitation characterizes chronic heart failure, but the contribution of transient receptor potential ankyrin 1 (TRPA1) channel-mediated cardiac and pulmonary reflexes to this sympathoexcitation was unknown.
Contrary to expectations, reflex responses to cardiopulmonary spinal afferent TRPA1 stimulation are attenuated rather than enhanced in chronic heart failure rats.
Excessive sympathoexcitation characterizes the chronic heart failure (CHF) state. An exaggerated cardiac sympathetic afferent reflex (CSAR) contributes to this sympathoexcitation. Prior studies have demonstrated that the CSAR to capsaicin [transient receptor potential (TRP) vanilloid 1 agonist] is exaggerated in CHF animal models. We recently discovered that capsaicin application to the lung visceral pleura in anesthetized, vagotomized, open-chested rats increases mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA). We named this response the pulmonary spinal afferent reflex (PSAR). Due to the similarities between TRP vanilloid 1 and TRP ankyrin 1 (TRPA1) channels as well as the excessive sympathoexcitation of CHF, we hypothesized that stimulation of the CSAR and PSAR with a specific TRPA1 agonist would result in an augmented response in CHF rats (coronary ligation model) compared with sham control rats. In response to a TRPA1 agonist, both CSAR and PSAR in sham rats resulted in biphasic changes in MAP and increases in HR and RSNA 10-12 wk postmyocardial infarction (post-MI). These effects were blunted in CHF rats. Assessment of TRPA1 expression levels in cardiopulmonary spinal afferents by immunofluorescence, quantitative RT-PCR, and Western blot analysis 10-12 wk post-MI all indicates reduced expression in CHF rats but no reduction at earlier time points. TRPA1 protein was reduced in a dorsal root ganglia cell culture model of inflammation and simulated tissue ischemia, raising the possibility that the in vivo reduction of TRPA1 expression was, in part, caused by CHF-related tissue ischemia and inflammation. These data provide evidence that reflex responses to cardiopulmonary spinal afferent TRPA1 stimulation may be attenuated in CHF rather than enhanced. NEW & NOTEWORTHY Excessive sympathoexcitation characterizes chronic heart failure (CHF). The contribution of transient receptor potential ankyrin 1 (TRPA1) channel-mediated reflexes to this sympathoexcitation is unknown. We found that application of TRPA1 agonist to the heart and lung surface resulted in increased heart rate and sympathetic output and a biphasic change in mean arterial pressure in control rats. These effects were attenuated in CHF rats, decreasing the likelihood that TRPA1 channels contribute to cardiopulmonary afferent sensitization in CHF.
No takes yet. Share an insight, caveat, or question.
Adam et al. (2019) studied Chronic heart failure. TRPA1 agonist application to the heart and lung surface vs. Sham control rats was evaluated on Changes in mean arterial pressure, heart rate, and renal sympathetic nerve activity. Application of a TRPA1 agonist to the heart and lung surface resulted in attenuated increases in heart rate, sympathetic output, and mean arterial pressure in chronic heart failure rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: